Well-characterized assays for a growing selection of viruses Now Available! VSV-SARS-CoV2 Neutralization Assay
Assays for a wide selection of gram-positive and gram-negative bacteria
Now Available! New Reagents for Coronavirus research Full-Length Spike Protein, Soluble Receptor Binding Domain, Nucleocapsid Protein, and Polyclonal Antibodies.
Antiviral & antibacterial disease models – Immunogenicity testing, Pharmacokinetics & toxicity
About IBT
The IBT Bioservices mission is to provide top client value by applying our infectious disease expertise, collaborative scientific interaction, and a flexible, cost-effective business model. The result is timely and relevant data for our clients’ needs.
Our scientists are leaders in their areas and can provide the highest level of expertise for your R&D programs. Read more about IBT.
Spotlight On: